Is diazepam (Valium) used to treat muscle spasms?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 26, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Is Diazepam Used for Muscle Spasms?

Yes, diazepam is FDA-approved and clinically indicated for the relief of skeletal muscle spasm, though it is not the preferred first-line agent in most clinical scenarios, particularly in elderly patients. 1

FDA-Approved Indications

Diazepam is specifically indicated as a useful adjunct for the relief of skeletal muscle spasm in two clinical contexts 1:

  • Reflex spasm due to local pathology (such as inflammation of muscles or joints, or secondary to trauma)
  • Spasticity from upper motor neuron disorders (including cerebral palsy, paraplegia, athetosis, and stiff-man syndrome)

Clinical Context and Positioning

While diazepam has documented efficacy for muscle spasm, its role in treatment algorithms varies significantly by patient population and clinical scenario:

Acute Muscle Spasm Management

  • Diazepam may be justified for a trial of muscle spasm relief, especially when anxiety, muscle spasm, and pain coexist 2
  • However, benzodiazepines have no direct analgesic effect, and their high-risk profile in older adults usually negates any potential benefit 2
  • For acute radiculopathy, diazepam showed no benefit over placebo for functional improvement and was less likely to provide adequate pain relief (41% vs 79% achieving ≥50% pain relief at 1 week) 3

Chronic Muscle Spasm and Spasticity

  • Baclofen is the preferred first-line agent for chronic muscle spasm and spasticity, particularly in elderly patients, with starting doses of 5 mg three times daily 2, 4
  • Diazepam should be avoided during stroke recovery due to possible deleterious effects on neurological recovery 4
  • Most muscle relaxants, including benzodiazepines, do not directly relax skeletal muscle and have no evidence of efficacy in chronic pain management 2

Important Safety Considerations

Risk Profile in Elderly Patients

  • Muscle relaxants as a class, including benzodiazepines, are listed in the American Geriatrics Society Beers Criteria as potentially inappropriate medications due to anticholinergic effects, sedation, and increased risk of falls 2
  • Benzodiazepines are associated with significantly increased central nervous system adverse events including somnolence, fatigue, and lightheadedness 3
  • In trials of rheumatoid arthritis patients, diazepam use resulted in a number needed to harm of 3 (95% CI 2-7) for adverse events, predominantly drowsiness and dizziness 5

Specific Clinical Scenarios Where Diazepam May Be Appropriate

Acute seizure management: Diazepam (rectal or IV) is recommended for status epilepticus when IV access is not available or as initial treatment 3

Tetanus-related muscle spasm: Diazepam infusion has documented efficacy for severe muscle spasms and rigidity associated with tetanus, with therapeutic serum concentrations around 500 ng/mL 6

Pediatric muscle spasm: In pediatric emergencies, diazepam may be used for sedation/anxiolysis at doses of 0.05-0.10 mg/kg IV 3

Treatment Algorithm for Muscle Spasm

When true muscle spasm or spasticity is confirmed 2, 7:

  1. First-line: Baclofen 5 mg three times daily, titrated gradually (maximum 30-40 mg/day in elderly) 2, 4
  2. Second-line: Tizanidine starting at 2 mg, titrated slowly 2, 4
  3. Focal spasticity: Botulinum toxin injections (superior to oral agents) 7
  4. Severe refractory cases: Intrathecal baclofen pump 7

Diazepam may be considered when anxiety, muscle spasm, and pain coexist, but only for short-term use due to the high-risk profile 2

Critical Pitfalls to Avoid

  • Do not use diazepam for chronic pain management without confirmed true muscle spasm or spasticity, as benzodiazepines lack direct analgesic effects 2
  • Avoid in elderly patients whenever possible due to fall risk, sedation, and cognitive impairment 2, 4
  • Do not prescribe long-term as the effectiveness beyond 4 months has not been established, and risk of dependence increases 1
  • Never abruptly discontinue after prolonged use; implement slow tapering to prevent withdrawal symptoms 4
  • Avoid during stroke recovery as it may impair neurological recovery 4
  • Consider non-pharmacological approaches first including stretching, massage, ice application, and physical therapy 4

References

Guideline

Safe Muscle Relaxants for Elderly Patients with Impaired Renal Function and Orthostatic Hypotension

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Management of Muscle Spasm

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Muscle relaxants for pain management in rheumatoid arthritis.

The Cochrane database of systematic reviews, 2012

Guideline

Management of Refractory Continuous Muscle Spasms

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.